Correspondence

On the ESPEN guidelines for nutritional screening 2002

Controversies exist as to the suitability of various nutrition screening tools for various age groups, the incorporation of age and age-related criteria into some tools, and the procedures associated with tool selection.

Reviews of the literature and national and local datasets were used to identify the types of screening tools available for different age groups, the origins of age-related criteria, and the value of tool selection procedures based on predicting clinical outcomes.

Nutrition screening can be undertaken in fetuses, children, and adults over narrow or wide age ranges, for diagnostic or prognostic purposes, with or without nutritional interventions. Certain tools can establish malnutrition risk without using any nutritional criteria, whereas others can do so only with nutritional criteria. The incorporation of age and age-specific body mass index criteria into adult screening tools can influence the prevalence and age distribution of malnutrition, but no justification is usually provided for their use. In several circumstances, age alone can predict mortality and length of hospital stay much better than screening tools. We identified various methodologic problems in nutrition screening tool selection.

A comparison of nutrition screening tools designed for different age groups and different purposes can be problematic. Age and screening tools incorporating risk factors that are non-modifiable or generally weakly modifiable by nutritional support (e.g., age, disease severity) may predict outcomes of disease, but they are not necessarily suitable for predicting outcomes of nutritional support. To contextualize the findings, a framework for screening tool selection is suggested that takes into account a matrix of needs.

Although various nutrition screening tools are used, they are not specific for the screening of malnourished cancer patients. The objective of this study was to develop a nutrition screening tool that could be used to identify cancer patients at risk for malnutrition.

Of 3010 cancer patients admitted to the National Cancer Center of Korea between April 1 and June 2, 2008, the nutritional status of 1057 patients was assessed by the Scored Patient-Generated Subjective Global Assessment (PG-SGA). Variables used in current nutrition screening tools were analyzed to select indices for a developing malnutrition screening tool for cancer patients (MSTC). The equation for the MSTC was established using receiver operating characteristics curves. Sensitivities and specificities of the MSTC were calculated using the PG-SGA as gold standard.

The MSTC was calculated as follows: [MSTC = −0.116 + (1.777 × intake change) + (1.304 × Eastern Cooperative Oncology Group performance status) + (1.568 × weight loss) + (−0.187 × body mass index)]. The MSTC had a sensitivity of 94.0%, a specificity of 84.2%, and high agreement (κ = 0.70, P < 0.0001) with the PG-SGA.

The MSTC appears to be a valid nutrition screening tool for determining nutritional risk in hospitalized cancer patients.

Due to the ageing of the population in the Western world, a significant increase in the number of older patients diagnosed with neoplastic diseases is observed. Hence, there is an emerging need for tools to efficiently evaluate older patients’ functional and global status. These tools can allow treating oncologists to better select patients, to propose treatment modifications, implement supportive measures and develop interventions to decrease the risk of toxicity and in general better tailor the treatment plan on an individual level. Currently significant uncertainty exists about the optimal tools and strategy for geriatric assessment, but on the other hand there is more than enough evidence that (some form of) geriatric assessment detects many previously unrecognised problems, and allows directed intervention which can improve outcome and compliance of proposed treatments. In the present paper, we discuss the most commonly used and studied tools for the assessment of functional status of older cancer patients.